acetylcysteine has been researched along with Atherosclerosis in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 15 (48.39) | 24.3611 |
| 2020's | 6 (19.35) | 2.80 |
| Authors | Studies |
|---|---|
| Doulamis, IP; Iliopoulos, DC; Kaminiotis, VV; Kapelouzou, A; Kontogiannis, C; Mastrogeorgiou, M; Mylonas, KS; Nikiteas, N; Siasos, G; Spartalis, E; Spartalis, M; Toutouzas, K | 1 |
| Bu, H; Chen, Y; Cui, L; Cui, Y; Gong, X; Hu, K; Jiang, Y; Liu, Q; Ma, X; Si, Z; Sun, H; Xu, Y; Zhu, Q; Zhuo, X | 1 |
| Cui, Y; Flaker, GC; Hao, H; Jiang, M; Liu, Q; Liu, X; Liu, Z; Xiao, Y; Zhou, S; Zhu, Q | 1 |
| Chen, SY; Cui, Y; Hao, H; Hill, MA; Li, DP; Liu, X; Liu, Z; Martinez-Lemus, LA; Wang, M; Wu, H; Xia, X; Xu, C; Zhang, L; Zhu, Q | 1 |
| Kuo, CC; Lee, GL; Lin, P; Wen, HT; Wu, JY; Yeh, CC | 1 |
| Fang, X; Liu, L; Wang, B; Zhou, S; Zhu, M | 1 |
| Bakoyiannis, C; Iliopoulos, D; Kapelouzou, A; Liakakos, T; Mastrogeorgiou, M; Mylonas, KS; Nikiteas, N; Schizas, D; Spartalis, E; Spartalis, M | 1 |
| Müller, GA; Patschan, D | 1 |
| Accili, D; Ferrante, AW; Murphy, AJ; Subramanian, V; Tall, AR; Tsuchiya, K; Westerterp, M | 1 |
| Damdindorj, L; Hosokawa, Y; Hossain, E; Karnan, S; Konishi, H; Konishi, Y; Ota, A; Takahashi, M | 1 |
| Chen, CS; Cho, HJ; Hseu, YC; Lin, CW; Lin, SW; Lu, FJ; Senthil Kumar, KJ; Shen, PC; Yang, HL | 1 |
| Eggermont, K; Feng, Y; Gao, M; Liu, G; Schouteden, S; Sorci-Thomas, MG; Van Veldhoven, PP; Verfaillie, CM; Zhao, D | 1 |
| Cui, L; Cui, Y; Hao, H; He, G; Li, X; Liu, L; Liu, PZ; Liu, Z; Narasimhulu, CA; Parthasarathy, S; Xiao, Y; Xie, X; Zhang, J; Zhang, Q | 1 |
| Barnado, A; Crofford, LJ; Oates, JC | 1 |
| Aguirre, MA; Barbarroja, N; Collantes-Estevez, E; Cuadrado, MJ; Jimenez-Gomez, Y; López-Pedrera, C | 1 |
| Gollavilli, PN; Gopoju, R; Karnewar, S; Kotamraju, S; Kumar, JM; Narra, SR; Vasamsetti, SB | 1 |
| Cho, JH; Choi, JY; Kim, CD; Kim, YJ; Kim, YL; Oh, EJ; Oh, SH; Park, SH; Ryu, HM | 1 |
| Ishisaka, A; Kanazawa, S; Kato, Y; Kettle, AJ; Kitamoto, N; Miura, Y; Naito, M; Oki, K; Ono, S; Suga, N | 1 |
| Augé, N; Bando, Y; Marachet, MA; Muller, C; Nègre-Salvayre, A; Salvayre, R; Sanson, M; Sawa, Y; Thiers, JC; Vindis, C; Zarkovic, K | 1 |
| Kishimoto, C; Kita, T; Lee, JD; Murayama, T; Shimada, K; Ueda, T; Uzui, H; Yokode, M | 1 |
| Cui, JH; Li, YL; Li, ZX; Meng, XP; Wang, L; Wang, YW; Yin, CS | 1 |
| Carrier, M; Farhat, N; Ferbeyre, G; Mallette, FA; Mamarbachi, AM; Perrault, LP; Thorin, E; Thorin-Trescases, N; Villeneuve, L; Voghel, G | 1 |
| Jang, SW; Kim, J; Kim, Y; Ko, J; Sung, HJ | 1 |
| Ieiri, I; Iwase, M; Kitazono, T; Matsuyama, N; Ohdo, S; Sonoki, K; Takata, Y | 1 |
| Morrison, DC; Papasian, CJ; Qureshi, AA; Qureshi, N; Van Way, C; Vogel, SN | 1 |
| Bernhard, D; Csordas, A; Henderson, B; Kind, M; Rossmann, A; Wick, G | 1 |
| De Oliveira, MG; Estrela, HF; Franchini, KG; Krieger, MH; Laurindo, FR; Santos, KF; Santos, L; Shishido, SM; Spadari-Bratfisch, RC; Wanschel, AC | 1 |
| Ikeda, D; Ishimaru, S; Itoh, N; Kamigaki, M; Nishimura, M; Ohira, H; Ohtsuka, Y; Sakaue, S; Tsujino, I | 1 |
| Griffiths, HR; Luan, Y | 1 |
| Chen, JW; Chen, YH; Chen, YL; Li, CY; Lin, FY; Lin, SJ; Tasi, JS; Wang, HJ; Yang, TL | 1 |
| Carrier, M; Farhat, N; Fortier, A; Mamarbachi, AM; Perrault, LP; Thorin, E; Thorin-Trescases, N; Villeneuve, L; Voghel, G | 1 |
4 review(s) available for acetylcysteine and Atherosclerosis
| Article | Year |
|---|---|
[Acute Kidney Injury, AKI - Update 2018].
Topics: Acetylcysteine; Acute Kidney Injury; Atherosclerosis; Clinical Trials as Topic; Contrast Media; Hematopoietic Stem Cell Transplantation; Humans; Multicenter Studies as Topic; Sodium Bicarbonate; Sodium Chloride; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases.
Topics: Acetylcysteine; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal; Antimalarials; Apoptosis; Atherosclerosis; Autoantigens; Autoimmune Diseases; Biomarkers; Deoxyribonuclease I; Extracellular Traps; Female; Humans; Hydrolases; Immunosuppressive Agents; Interferon-alpha; Lupus Erythematosus, Systemic; Molecular Targeted Therapy; Neutrophils; Pregnancy; Pregnancy Complications; Protein Processing, Post-Translational; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Thrombophilia; Thrombosis; Translational Research, Biomedical; Vitamin D | 2016 |
Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches.
Topics: Acetylcysteine; Anticoagulants; Antioxidants; Antiphospholipid Syndrome; Atherosclerosis; Autoantibodies; beta 2-Glycoprotein I; Coagulants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lupus Erythematosus, Systemic; Mitochondrial Diseases; Oxidative Stress; Reactive Oxygen Species; Recurrence; Thrombosis; Ubiquinone | 2016 |
The proteasome: a central regulator of inflammation and macrophage function.
Topics: Acetylcysteine; Aging; Animals; Atherosclerosis; Cholesterol; Humans; Inflammation; Lipopolysaccharides; Macrophages; Mice; Neurodegenerative Diseases; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Shock, Hemorrhagic; Signal Transduction; Toll-Like Receptor 2 | 2005 |
1 trial(s) available for acetylcysteine and Atherosclerosis
| Article | Year |
|---|---|
Telmisartan and N-acetylcysteine suppress group V secretory phospholipase A2 expression in TNFα-stimulated human endothelial cells and reduce associated atherogenicity.
Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Atherosclerosis; Benzimidazoles; Benzoates; Chemokine CCL2; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Group V Phospholipases A2; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Middle Aged; RNA, Messenger; Telmisartan; Tumor Necrosis Factor-alpha | 2012 |
26 other study(ies) available for acetylcysteine and Atherosclerosis
| Article | Year |
|---|---|
The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits.
Topics: Acetylcysteine; Administration, Oral; Animals; Anti-Inflammatory Agents; Aorta; Atherosclerosis; C-Reactive Protein; Cholesterol; Colchicine; Drug Therapy, Combination; Fenofibrate; Hypolipidemic Agents; Interleukin-6; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Rabbits; Triglycerides | 2021 |
N‑acetyl cysteine prevents ambient fine particulate matter‑potentiated atherosclerosis via inhibition of reactive oxygen species‑induced oxidized low density lipoprotein elevation and decreased circulating endothelial progenitor cell.
Topics: Acetylcysteine; Animals; Atherosclerosis; Endothelial Progenitor Cells; Lipoproteins, LDL; Mice; Particulate Matter; Reactive Oxygen Species | 2022 |
N-acetylcysteine attenuates atherosclerosis progression in aging LDL receptor deficient mice with preserved M2 macrophages and increased CD146.
Topics: Acetylcysteine; Aging; Animals; Atherosclerosis; CD146 Antigen; Diet, High-Fat; Hyperlipidemias; Inflammation; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Reactive Oxygen Species; Receptors, LDL | 2022 |
Helicobacter pylori infection selectively attenuates endothelial function in male mice
Topics: Acetylcysteine; Animals; Atherosclerosis; Endothelial Cells; Endothelium; Exosomes; Female; Helicobacter Infections; Helicobacter pylori; Male; Mice; Mice, Inbred C57BL; Reactive Oxygen Species | 2023 |
Vanadium Derivative Exposure Promotes Functional Alterations of VSMCs and Consequent Atherosclerosis via ROS/p38/NF-κB-Mediated IL-6 Production.
Topics: Acetylcysteine; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cell Differentiation; Cell Movement; Cell Proliferation; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microfilament Proteins; Muscle Proteins; Muscle, Smooth, Vascular; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Signal Transduction; Vanadates | 2019 |
N‑acetylcysteine inhibits atherosclerosis by correcting glutathione‑dependent methylglyoxal elimination and dicarbonyl/oxidative stress in the aorta of diabetic mice.
Topics: Acetylcysteine; Animals; Aorta; Atherosclerosis; Diabetes Complications; Diabetes Mellitus, Experimental; Glutathione; Male; Mice; Mice, Knockout, ApoE; Oxidative Stress; Pyruvaldehyde | 2021 |
KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; Colchicine; Disease Models, Animal; Drug Therapy, Combination; Fibric Acids; Hyperlipidemias; Kruppel-Like Factor 4; Male; Plaque, Atherosclerotic; Rabbits; Up-Regulation | 2022 |
Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Atherosclerosis; Cell Cycle Proteins; Cysteine; Female; Forkhead Box Protein O1; Forkhead Box Protein O3; Forkhead Transcription Factors; Free Radical Scavengers; Hematopoietic Stem Cells; Insulin; Macrophages; Male; Mice; Mice, Knockout; Monocytes; Neutrophils; Nitrogen; Oxidative Stress; Proto-Oncogene Proteins c-akt; Signal Transduction; Tyrosine | 2013 |
Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
Topics: Acetylcysteine; Animals; Aorta; Arsenites; Atherosclerosis; Caffeic Acids; Cell Line; Endothelial Cells; Lipoproteins, LDL; Mice; NF-kappa B; Phenylethyl Alcohol; Phosphorylation; Reactive Oxygen Species; RNA, Messenger; Scavenger Receptors, Class E; Signal Transduction; Sodium Compounds; Up-Regulation | 2013 |
Humic acid in drinking well water induces inflammation through reactive oxygen species generation and activation of nuclear factor-κB/activator protein-1 signaling pathways: a possible role in atherosclerosis.
Topics: Acetylcysteine; Animals; Antioxidants; Atherosclerosis; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Dinoprostone; Drinking Water; Female; Gene Expression Regulation; Heme Oxygenase-1; Humic Substances; Inflammation; Interleukin-1beta; Membrane Proteins; Mice; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Reactive Oxygen Species; Signal Transduction; Taiwan; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2014 |
Regulation of high-density lipoprotein on hematopoietic stem/progenitor cells in atherosclerosis requires scavenger receptor type BI expression.
Topics: Acetylcysteine; Animals; Apolipoprotein A-I; Atherosclerosis; Bone Marrow Transplantation; Cell Division; Diet, Atherogenic; Disease Progression; Hematopoietic Stem Cells; Humans; Hypercholesterolemia; Leukocytosis; Lipoproteins, HDL; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Radiation Chimera; Reactive Oxygen Species; Receptors, LDL; Scavenger Receptors, Class B | 2014 |
N-acetylcysteine inhibits in vivo oxidation of native low-density lipoprotein.
Topics: Acetylcysteine; Animals; Antioxidants; Atherosclerosis; Humans; Hyperlipidemias; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Reactive Oxygen Species; Receptors, LDL | 2015 |
Resveratrol attenuates monocyte-to-macrophage differentiation and associated inflammation via modulation of intracellular GSH homeostasis: Relevance in atherosclerosis.
Topics: Acetylcysteine; AMP-Activated Protein Kinases; Animals; Antioxidants; Apolipoproteins E; Atherosclerosis; Buthionine Sulfoximine; Cell Differentiation; Glutathione; Homeostasis; Humans; Inflammation; Macrophages; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Monocytes; Resveratrol; Stilbenes; Tetradecanoylphorbol Acetate | 2016 |
Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E-deficient mice and cells.
Topics: Acetylcysteine; Allopurinol; Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Down-Regulation; Hep G2 Cells; Humans; Hydrogen Peroxide; Hypercholesterolemia; Hypoxanthine; Lipogenesis; Male; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Plaque, Atherosclerotic; Up-Regulation | 2016 |
A novel quinone derived from 5-hydroxyindoleacetic acid reacts with protein: Possible participation of oxidation of serotonin and its metabolite in the development of atherosclerosis.
Topics: Acetylcysteine; Aged; Antibodies, Monoclonal; Aorta; Atherosclerosis; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Hydroxyindoleacetic Acid; Immunohistochemistry; Male; Microtomy; Peroxidase; Phenylenediamines; Quinones; Serotonin; Xanthine Oxidase | 2016 |
Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: prevention by oxygen-regulated protein 150 expression.
Topics: Acetylcysteine; Aldehydes; Apoptosis; Atherosclerosis; Biomarkers; Cysteine Proteinase Inhibitors; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endothelial Cells; Enzyme Inhibitors; Free Radical Scavengers; HSP70 Heat-Shock Proteins; Humans; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; Ketocholesterols; Lipoproteins, LDL; Oxygen; Proteins; Stress, Physiological | 2009 |
N-acetylcysteine reduces the severity of atherosclerosis in apolipoprotein E-deficient mice by reducing superoxide production.
Topics: Acetylcysteine; Animals; Apolipoproteins E; Atherosclerosis; Dietary Fats; Disease Models, Animal; Free Radical Scavengers; Intercellular Adhesion Molecule-1; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Oxidative Stress; Severity of Illness Index; Superoxides | 2009 |
[Inhibitory effect of N-acetylcysteine upon atherosclerotic processes in rabbit carotid].
Topics: Acetylcysteine; Animals; Atherosclerosis; Carotid Arteries; Disease Models, Animal; Lipoproteins, LDL; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Rabbits | 2009 |
Endogenous oxidative stress prevents telomerase-dependent immortalization of human endothelial cells.
Topics: Acetylcysteine; Aged; Atherosclerosis; Cells, Cultured; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Endothelial Cells; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Oxidative Stress; Risk; Telomerase; Tumor Suppressor Protein p53 | 2010 |
N-acetyl cysteine suppresses the foam cell formation that is induced by oxidized low density lipoprotein via regulation of gene expression.
Topics: Acetylcysteine; Apolipoproteins E; Atherosclerosis; Biomarkers; Cell Line, Tumor; DNA Primers; Foam Cells; Gene Expression Profiling; Gene Expression Regulation; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Lipoproteins, LDL; Microarray Analysis; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction | 2012 |
Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules.
Topics: Acetylcysteine; Antioxidants; Atherosclerosis; Calcium; Catalysis; Cells, Cultured; Endothelial Cells; Humans; Interleukin-6; Interleukin-8; Metals; Microtubules; Nicotiana; Oxidative Stress; P-Selectin; Paclitaxel; Platelet Endothelial Cell Adhesion Molecule-1; Proteins; Smoke; Tubulin; Vasoconstriction | 2005 |
Antiatherogenic effects of S-nitroso-N-acetylcysteine in hypercholesterolemic LDL receptor knockout mice.
Topics: Acetylcysteine; Animals; Atherosclerosis; Blotting, Western; Hypercholesterolemia; Immunohistochemistry; Mice; Mice, Knockout; Nitric Oxide Donors; Nitric Oxide Synthase; Receptors, LDL | 2006 |
Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Acetylcysteine; Adipocytes; Adiponectin; Animals; Atherosclerosis; Gene Expression Regulation; Glucose Oxidase; Hydrogen Peroxide; Leptin; Mice; Oxidative Stress; Peptide Hormones; Plasminogen Activator Inhibitor 1; Resistin; RNA, Messenger | 2006 |
Ceramides reduce CD36 cell surface expression and oxidised LDL uptake by monocytes and macrophages.
Topics: Acetylcysteine; Atherosclerosis; CD36 Antigens; Ceramides; Gene Expression Regulation; Humans; Lipoproteins, LDL; Macrophages; Proteasome Endopeptidase Complex; Protein Transport; RNA, Messenger; U937 Cells | 2006 |
Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways.
Topics: Acetophenones; Acetylcysteine; Animals; Aorta; Atherosclerosis; Cells, Cultured; Endotoxins; Enzyme Inhibitors; Free Radical Scavengers; Gene Expression Regulation; Humans; Inflammation; Lipopolysaccharides; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth, Vascular; NADPH Oxidases; Onium Compounds; Rabbits; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4 | 2006 |
Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients.
Topics: Acetylcysteine; Aged; Antioxidants; Atherosclerosis; Cells, Cultured; Cellular Senescence; Endothelial Cells; Endothelium, Vascular; Female; Humans; Lipid Peroxidation; Male; Mammary Arteries; Middle Aged; Organ Culture Techniques; Oxidative Stress; Telomerase | 2008 |